Clover Health Investments CLOV Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Operating margin | -2.6%+1.9pp | -4.4%-1.2pp | -3.3%-0.6pp | -2.6%-1.0pp | -1.6%+1.7pp | |
| Net margin | -2.6%+1.9pp | -4.4%-1.2pp | -3.3%-0.6pp | -2.7%-1.0pp | -1.7%+1.4pp | |
| EBITDA margin | -2.5%+1.9pp | -4.4%-1.2pp | -3.2%-0.6pp | -2.5%-1.0pp | -1.5%+1.7pp | |
| Returns | ||||||
| Return on equity | -16.9%+9.5pp | -26.3%-9.3pp | -17.1%-4.2pp | -12.9%-4.9pp | -8%+5.7pp | |
| Return on assets | -8.9%+6.4pp | -15.3%-5.6pp | -9.6%-2.7pp | -6.9%-2.9pp | -4%+3.5pp | |
| Efficiency | ||||||
| Asset turnover | 3.5×0.0× | 3.4×+0.5× | 2.9×+0.4× | 2.6×+0.2× | 2.4×0.0× | |
| Liquidity | ||||||
| Current ratio | 1.3×-0.1× | 1.5×-0.2× | 1.7×-0.1× | 1.8×+0.3× | 1.5×-0.1× | |
| Quick ratio | 1.3×-0.1× | 1.5×-0.2× | 1.7×-0.1× | 1.8×+0.3× | 1.5×-0.1× | |
| Cash ratio | 0.5×+0.1× | 0.4×-0.6× | 1×0.0× | 0.9×+0.2× | 0.7×-0.2× | |
| Per Share | ||||||
| Book value per share | $0.64+5.7% | $0.60-9.3% | $0.66-1.7% | $0.680.0% | $0.68-2.9% | |
| Valuation | ||||||
| Market capitalization | $923.41M-23.9% | $1.21B-22.6% | $1.57B+8.5% | $1.45B-21.2% | $1.83B+16.2% | |
| Price / sales | 0.4×-0.2× | 0.6×-0.3× | 0.9×0.0× | 0.9×-0.3× | 1.2×+0.1× | |
| Price / book | 2.7×-1.2× | 3.9×-0.7× | 4.6×+0.4× | 4.2×-1.3× | 5.5×+0.8× | |
| Earnings yield | -6.2%+0.9pp | -7%-3.3pp | -3.7%-0.7pp | -3%-1.6pp | -1.4%+1.4pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Clover Health Investments's ratios come from?
- Every ratio is computed from Clover Health Investments's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.